chr17-80994650-C-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_024591.5(CHMP6):c.133C>T(p.Arg45Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000581 in 1,583,604 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00014 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000050 ( 0 hom. )
Consequence
CHMP6
NM_024591.5 missense
NM_024591.5 missense
Scores
6
11
2
Clinical Significance
Conservation
PhyloP100: 0.0960
Genes affected
CHMP6 (HGNC:25675): (charged multivesicular body protein 6) This gene encodes a member of the chromatin-modifying protein/charged multivesicular body protein family. Proteins in this family are part of the ESCRT-III (endosomal sorting complex required for transport III) which degrades surface receptors, and in biosynthesis of endosomes. [provided by RefSeq, Mar 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.815
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CHMP6 | NM_024591.5 | c.133C>T | p.Arg45Cys | missense_variant | 2/8 | ENST00000325167.9 | NP_078867.2 | |
CHMP6 | XM_005257668.1 | c.133C>T | p.Arg45Cys | missense_variant | 2/7 | XP_005257725.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CHMP6 | ENST00000325167.9 | c.133C>T | p.Arg45Cys | missense_variant | 2/8 | 1 | NM_024591.5 | ENSP00000317468.5 | ||
CHMP6 | ENST00000572778.5 | c.70C>T | p.Arg24Cys | missense_variant | 1/6 | 2 | ENSP00000461098.1 | |||
CHMP6 | ENST00000571457.1 | c.7C>T | p.Arg3Cys | missense_variant | 1/7 | 3 | ENSP00000461238.1 | |||
CHMP6 | ENST00000572525.5 | c.-126C>T | 5_prime_UTR_variant | 2/8 | 3 | ENSP00000460389.1 |
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152172Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
21
AN:
152172
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000420 AC: 8AN: 190300Hom.: 0 AF XY: 0.0000387 AC XY: 4AN XY: 103228
GnomAD3 exomes
AF:
AC:
8
AN:
190300
Hom.:
AF XY:
AC XY:
4
AN XY:
103228
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000496 AC: 71AN: 1431432Hom.: 0 Cov.: 31 AF XY: 0.0000522 AC XY: 37AN XY: 709108
GnomAD4 exome
AF:
AC:
71
AN:
1431432
Hom.:
Cov.:
31
AF XY:
AC XY:
37
AN XY:
709108
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000138 AC: 21AN: 152172Hom.: 0 Cov.: 32 AF XY: 0.000188 AC XY: 14AN XY: 74344
GnomAD4 genome
AF:
AC:
21
AN:
152172
Hom.:
Cov.:
32
AF XY:
AC XY:
14
AN XY:
74344
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
2
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 06, 2022 | The c.133C>T (p.R45C) alteration is located in exon 2 (coding exon 2) of the CHMP6 gene. This alteration results from a C to T substitution at nucleotide position 133, causing the arginine (R) at amino acid position 45 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
D;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Benign
D
LIST_S2
Pathogenic
D;D;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D
MetaSVM
Uncertain
D
MutationAssessor
Pathogenic
M;.;.
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;.;.
REVEL
Uncertain
Sift
Uncertain
D;.;.
Sift4G
Uncertain
D;D;D
Polyphen
D;.;.
Vest4
MVP
MPC
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at